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CO R R E S POND EN C E : O U R E X P E R I E N C E
A review of periorbital cellulitis guidelines in Fifty-One Acute
Admitting Units in the United Kingdom
1 | INTRODUCTION
Periorbital cellulitis is an acute infection of the periorbital soft tis-
sues with potential sight and life-threatening complications that most
commonly occurs in children.1 Post-septal abscess formation can
cause loss of sight; furthermore, posterior spread of infection may
progress to cavernous sinus thrombosis and intracranial infection.1,2
In England April 2014-March 2015, 3687 patients attended hospital
with periorbital cellulitis costing the National Health Service over
£9.5 million per annum before considering the cost of treating its
complications.3
Management of periorbital cellulitis is complex, and it is not
uncommon for patients to fall between up to three specialties: oto-
laryngology, ophthalmology and paediatrics (depending on the age of
the patient). Otolaryngologists may aid with ascertaining the aetiol-
ogy of the condition as well as providing surgical intervention.
The objective of this study was to establish the current perior-
bital cellulitis management strategies in the United Kingdom (UK)
through analysis of the prevalence of guidelines and comparison
against evidence-based management.
2 | METHODS
Ethical consideration concluded that this study was a service evalua-
tion project.
Fifty-one acute admitting otolaryngology units were selected
from each regional Health Education Authority across the UK, with a
minimum of 2 per Health Education Authority and contacted via
telephone by AO. Units in each HEA were split into tertiary and
non-tertiary centres and arranged in alphabetical order. First on-call
otolaryngologists were contacted at each unit in alphabetical order,
if unreachable the next unit on the list was contacted. A tertiary and
non-tertiary care centre were contacted in each HEA.
3 | RESULTS
3.1 | Demographics
First on-call Otolaryngology doctors of various grades (Figure 1)
were contacted from 51 acute admitting units in the UK; 27 tertiary
referral units and 24 secondary referral units by telephone (Fig-
ure 2).
Twenty-three trusts of 51 (45.1%) were confirmed as having
24 guidelines (one unit had separate adult and paediatric guid-
ance) for the treatment of periorbital cellulitis. Eighteen of the 24
(75%) guidelines found were obtained from 17 trusts for analysis.
Three additional microbiology guidelines for the treatment of peri-
orbital cellulitis were obtained from three separate healthcare
trusts.
3.2 | Laboratory investigations (from 18 guidelines)
Six (33.3%) guidelines did not specify any laboratory investigations.
All other 12 (66.7%) guidelines specified a full blood count and C-
reactive protein level, 4 (22.2%) asked for urea and electrolytes
levels, 1 (5.6%) specified an erythrocyte sedimentation rate and 1
(5.6%) a serum lactate level.
3.3 | Microbiology
Three (16.7%) guidelines did not specify any microbiological investi-
gations. All remaining 15 (83.3%) guidelines specified a blood cul-
ture to be taken from patients; however, one of which only if the
patient was pyrexial. Seven (38.9%) guidelines required eye swabs
(one guideline recommends no eye swab because of the risk of
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contamination), 3 (16.7%) nasal swabs, 3 (16.7%) specified consider-
ing a lumbar puncture (if central nervous system signs or menin-
gism). One (5.6%) guideline specified streptococcus pneumoniae
and haemophilus influenzae PCR (polymerase chain reaction) tests
and 1 (5.6%) further guideline required the patient to undergo a
throat swab.
The choice of antibiotic (Figure 3) varied across the 18 guidelines
obtained and the 3 microbiology guidelines. Eleven (52.4%) units
covered anaerobes in their first-line antibiotics with metronidazole
(8), clindamycin (2) or topical chloramphenicol (1).
3.4 | Medical adjuncts
Nine (50%) guidelines suggested the use of medical adjuncts. Three
(16.7%) of the guidelines specified the use of xylometazoline
hydrochloride (Otrivine) nasal spray, 3 (16.7%) also specified topical
ephedrine, 1 (5.6%) oral pseudoephedrine (Sudafed), 1 specified
phenylephrine nasal drops, 1 (5.6%) beclomethasone nasal spray
(Beconase) and 2 (11.1%) guidelines asked for the use of nasal
decongestants but did not specify the drug or the route of adminis-
tration.
3.5 | Imaging
Three (16.7%) of the guidelines examined did not give any criteria
for imaging, while a further two (11.1%) recommend imaging all
patients with suspected periorbital cellulitis. The remaining 13
(72.2%) guidelines recommend imaging patients if they have any
central nervous system signs, eye signs (eg, diplopia, reduced visual
F IGURE 2 Acute admitting
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Keypoints
• There is a lack of readily available formal guidance
• Current guidelines lack first-line anaerobic cover
• Current guidelines are not clear on the use contrast-
enhanced CT orbit and paranasal sinuses
• Frequency of ophthalmology review in patients with
periorbital cellulitis is not clearly specified in current
guidelines
• Indications for surgical intervention in periorbital cellulitis
are not clearly stated
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acuity or ophthalmoplegia), inability to assess the patient’s eye or
failure to respond to intravenous antibiotics after 24-48 hours. The
preferred imaging modality varied between guidelines, Figure 4.
3.6 | Admission
Five (27.8%) guidelines identified had no criteria for admission, 8
(44.4%) specified all patients to be admitted. Five (27.8%) guidelines
required admission if patients are pyrexial, have eye symptoms such
as diplopia, reduced visual acuity or ophthalmoplegia or are generally
unwell or who have not improved after 24-48 hours of oral antibi-
otics. The lead specialty for admission varied between guidelines.
Six (33.3%) guidelines did not specify the frequency or extent of
cross-specialty review. Nine (50%) guidelines studied required Oph-
thalmology and Otolaryngology review for all patients admitted with
suspected periorbital cellulitis. One (5.6%) specified only Otolaryn-
gology review and two (11.1%) specified only ophthalmology review.
3.7 | Surgery
Ten (55.6%) of the guidelines examined did not specify surgical indi-
cations for patients with suspected periorbital cellulitis. One (5.6%)
guideline specified rapidly deteriorating vision as an indication for
surgery; 4 (22.2%) use radiological evidence of a periorbital abscess;
and two (11.1%) clinical suspicion of periorbital abscess as indica-
tions for surgery.
4 | DISCUSSION
4.1 | Clinical applicability
The most striking observation from this snapshot of orbital cellulitis
guidance was that less than half (45.1%) of units contacted had
formal guidance readily available for first on-call otolaryngologists
for an emergency that has sight and potentially life-threatening com-
plications. 72.5% of on-call doctors contacted were foundation doc-
tors, core trainees or GP trainees, therefore, likely inexperienced at
assessment of a relatively infrequent but serious pathology.
The most frequent complications of periorbital cellulitis are visual
and therefore specialist review by an Ophthalmologist should always
be sought. However, only 61.1% of guidelines specified ophthalmol-
ogy review for patients admitted with periorbital cellulitis, a sight-
threatening infection. Furthermore, frequency of review was often
not specified.
Imaging in periorbital cellulitis should occur if there is suspicion
of a subperiosteal, orbital or intracranial abscess. Clinical signs that
may indicate the above are specified in 72.2% of guidelines and
include but are not limited to: no clinical improvement after 24-
48 hours of best medical therapy, eye signs, inability to assess the
eye, or central nervous system signs. Predictive accuracy of subpe-
riosteal or orbital abscess by clinical judgment alone is 82%, this
increases to 91% after contrast CT, with MRI a useful tool in cases
of diagnostic uncertainty or a suspicion of intracranial complica-
tions.4 Less than a quarter (22.2%) of guidelines specified contrast
CT orbit and paranasal sinuses (half of these also included any indi-
cation of when a CT contrast brain scan should be performed), a
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further (5.6%) guideline required a CT orbit and paranasal sinuses
without specifying contrast status.
Initial treatment of periorbital cellulitis with no suspicion of sub-
periosteal/orbital abscess, or a small (<10 mm), medial subperiosteal
abscess in a young child (<9 years old) may consist of intravenous
antibiotics.2,4-8 Although 25% of surgical cultures in periorbital cel-
lulitis contain anaerobes only half (52.4%) of the units that returned
guidelines routinely covered anaerobic bacteria in first-line treat-
ment.9,10 Radiological evidence of an abscess that differs to what is
described above and clinical deterioration are all indications for sur-
gical intervention; less than half (44.4%) of guidelines specified these
indications for surgery.4
4.2 | Strengths of the study
This study contacted multiple units throughout all health education
authorities in the UK. First on-call doctors were consulted, as they
are likely to encounter periorbital cellulitis patients; therefore, guide-
lines are likely to be representative of patient management.
4.3 | Limitations
The ability to find appropriate protocols is user dependent, therefore
protocols might exist in some units that first on-call otolaryngologists
were unable to locate. However, if this is the case, it reflects the
dilemmas junior clinicians face. Six (25%) protocols were not
obtained, the contents of these are unknown and may have con-
tributed to a differing view of our results.
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